Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.

NCT01256125 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2010-12-08

No results posted yet for this study

Summary

Allogene MSCs transplantation will be performed in patients with chronic liver diseases through peripheral vein and therapeutic effects including short-term effects and long-term follow-up will be compared and investigated.

Conditions

  • Allogene MSCs Transplantation
  • Chronic Liver Diseases Patients
  • Peripheral Vein

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01256125 on ClinicalTrials.gov